Neil Chatterji

Stock Analyst at B. Riley Securities

(0.64)
# 2573
Out of 5,441 analysts
26
Total ratings
Success rate
Average return
12 Stocks
Name Action PT Current % Upside Ratings Updated
CLPT ClearPoint Neuro
Maintains: Strong Buy
20 28
10.6 164.15% 4 Apr 25, 2025
OPRX OptimizeRx
Maintains: Buy
17 13
16.21 -19.8% 3 Dec 24, 2024
AUGX Augmedix
Reinstates: Buy
6
2.35 134.04% 3 Apr 3, 2024
ESTA Establishment Labs H...
Maintains: Buy
95 50
33.61 48.77% 2 Nov 9, 2023
SILK Silk Road Medical
Downgrades: Neutral
54 14
27.49 -49.07% 3 Oct 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
8
1.35 455.56% 1 Oct 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
15 18
14.17 27.03% 2 Sep 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
5
4.05 11.11% 1 Sep 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
3 4
1.28 173.44% 3 Aug 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
6 6
2.54 116.54% 2 Mar 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
32
13.09 144.46% 1 Dec 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
10
1.36 598.53% 1 Oct 4, 2022